Public Profile

Tty Biopharm

Tty Biopharm Corporation, commonly referred to as Tty Biopharm, is a prominent player in the biopharmaceutical industry, headquartered in Taiwan (TW). Founded in 1966, the company has established itself as a leader in the development and manufacturing of innovative pharmaceuticals, particularly in oncology and other therapeutic areas. With a strong presence in both domestic and international markets, Tty Biopharm is renowned for its commitment to quality and research-driven solutions. The company’s core offerings include a diverse range of generic and proprietary medications, distinguished by their efficacy and safety profiles. Notable achievements include strategic partnerships and a robust pipeline of products that cater to unmet medical needs, solidifying Tty Biopharm's position as a trusted name in the biopharmaceutical landscape.

DitchCarbon Score

How does Tty Biopharm's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

40

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Tty Biopharm's score of 40 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.

74%

Let us know if this data was useful to you

Tty Biopharm's reported carbon emissions

In 2023, Tty Biopharm reported total carbon emissions of approximately 9,484,000 kg CO2e. This figure includes 1,700,220 kg CO2e from Scope 1 emissions, 8,488,800 kg CO2e from Scope 2 emissions, and 2,549,520 kg CO2e from Scope 3 emissions, which encompasses categories such as purchased goods and services (2,001,170 kg CO2e) and waste generated in operations (32,650 kg CO2e). Comparatively, in 2022, the company recorded total emissions of about 8,836,000 kg CO2e, with Scope 1 emissions at 1,535,320 kg CO2e, Scope 2 at 8,232,490 kg CO2e, and Scope 3 at 3,041,940 kg CO2e. This indicates an increase in total emissions from 2022 to 2023. Despite the increase in emissions, Tty Biopharm has not publicly disclosed specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of documented reduction targets suggests that the company may be in the early stages of developing a comprehensive climate strategy. Overall, Tty Biopharm's emissions data reflects a significant environmental impact, particularly in Scope 2 emissions, which are primarily associated with energy consumption. The company operates from its headquarters in Taiwan (TW) and is expected to enhance its climate commitments in alignment with industry standards.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20162017201820192020202120222023
Scope 1
1,219,000
000,000
0,000.0
000,000
000,000
000,000
0,000,000
0,000,000
Scope 2
6,845,000
0,000,000
000,000.0
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
Scope 3
8,065,000
0,000,000
0,000,000.0
00,000.0
00,000.0
00,000.0
0,000,000
0,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Tty Biopharm's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Tty Biopharm is in TW, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Tty Biopharm is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Sanofi Pasteur Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

MedImmune, LLC

US
Health and social work services (85)
Updated 4 months ago
DitchCarbon Score

Pfizer

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Sanofi

FR
Pharmaceutical Preparation Manufacturing
Updated about 13 hours ago

Plus Therapeutics, Inc.

US
Health and social work services (85)
Updated 22 days ago

Glaxosmithkline

GB
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers